Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEO-CM04S1 or mRNA Vaccine Booster in CLL Patients
NCT05672355Phase 2Completed
- Sponsor
- City of Hope
- Start
- Aug 2023
- Primary completion
- Jun 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GEO-CM04S1 in coronavirus disease 2019 (COVID-19), sponsored by City of Hope. Started Aug 2023; status: completed.
02
Drugs
GEO-CM04S1
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05672355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05672355.